Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- befree-2016 importedOn "2016-02-19" NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion wasGeneratedBy ECO_0000203 NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion wasDerivedFrom befree-2016 NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion SIO_000772 19924441 NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion evidence source_evidence_literature NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.
- NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_assertion description "[In the current pilot study, BC with p16 gene hypermethylation had a lower risk of recurrence after treatment with IL-2, as compared to IL-2 treated BC without p16 hypermethylation (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776713.RA7PWNL3l3NzJ_7Whz6_DC0TYowp5G-Sxfkt1aH977Bc4130_provenance.